Dr. Lebovics is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Ambulatory care Pavilion, 3rd floor
100 Woods Road
Valhalla, NY 10595Phone+1 914-533-4111Fax+1 914-449-1940
Summary
- Dr. Lebovics is the Upham Professor of Gastroenterology and Director of the Sarah C. Upham Division of Gastroenterology and Hepatobiliary Diseases at New York Medical College and Vice Chair for Clinical Affairs of the Department of Medicine. He is Chief of the Section of Gastroenterology and Hepatobiliary Diseases at Westchester Medical Center. He directed the gastroenterology fellowship training program 1997-2017. He serves on the Executive Committee of the Faculty Senate of NYMC and is a past-president of the Medical Executive Board of WMC.
Dr. Lebovics’ clinical expertise and research have made significant contributions in the fields of gastrointestinal and liver disease. His special interests include advanced therapeutic endoscopy, hepatitis C virus infection, chronic liver diseases, and inflammatory bowel disease. He has authored numerous articles and book chapters and delivered many invited lectures.
His achievements have been recognized by a Certificate of Special Congressional Recognition and by election to Fellowship at the American College of Physicians, American College of Gastroenterology and American Gastroenterological Association. He has been frequently listed amongst “Top Doctors” by New York Magazine and various other publications. Medical students and residents have also recognized his commitment to teaching through Excellence in Teaching Awards.
Education & Training
- NYMC-Westchester1984 - 1986
- Liver Diseases, Mt Sinai Hospital of CUNY1983 - 1984
- Washington University School of Medicine1981 - 1983
- Washington University School of Medicine1980 - 1981
- New York University School of MedicineClass of 1980
- Yeshiva UniversityB.A., Summa Cum Laude, 1976
Certifications & Licensure
- NY State Medical License 1983 - 2025
- CT State Medical License 1989 - 2011
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians)
- Westchester Magazine: Top Doctors Castle Connolly, 2004-2018
- Top Doctors: New York Metro Area Castle Connolly, 2002-2018
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsFontan-Associated Liver Disease: A Review.Gabriel Heering, Nachum Lebovics, Raksheeth Agarwal, William H Frishman, Edward Lebovics
Cardiology in Review. 2024-03-13 - 216 citationsPeginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: A randomized trialIra M. Jacobson, Robert S. Brown, B. Freilich, Nezam H. Afdhal, P. Kwo
Hepatology. 2007-10-01 - 13 citationsPrevalence of cannabis use has significantly increased in patients with cyclic vomiting syndrome.Mohamed Tausif Siddiqui, Mohammad Bilal, Amandeep Singh, Sarah Olivier-Cabrera, Edward Lebovics
Neurogastroenterology and Motility. 2020-01-28
Journal Articles
- Endoscopic laser therapy of GI bleeding.Heier SK, Lebovics E, Rosenthal WS, N Eng J Med 1988; 318:185-6 (letter)
- Photodynamic therapy of esophageal malignancy using dihematoporphyhrin ethers.Heier SK, Lebovics E, Rothman K, Rosenthal WS, Bollettino dell'Istituto Dermatologico S. Gallicano 1988; 13:195-202
- Breakthrough of interferon therapy.Lebovics E, Dworkin BM, Rosenthal WS, AM J Gastro 1996; 91, No10:2250. (letter)
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels.Sheikh AM, Wolf DC, Lebovics E, Goldberg R, Horowitz HW, Transplantation 1999;68:307-9
- Defining the normal diameter of the intrahepatic bile ducts on ERCP.Lee Y, Ligresti R, Kannam H, Kaza C, Lebovics E, Gastrointestinal Endoscopy 2003, Presented at DDW, Orlando FL
- Non- alcoholic steatohepatitis (NASH) increases hepatic inflammation and fibrosis in chronic hepatitis C (CHC). Final results.Lee Y, Ligresti R, Kalala S, Mackey J, Bloom P, Elhosseiny A, Rigas B, Lebovics E, Gastroenterology 2003;124:A-744, Presented at DDW, Orlando, FL
- Join now to see all
Lectures
- The Challenge of the Hepatitis C Non-Responder.Queens General Hospital, Dept. of Medicine
- Advances in the Management of Chronic Hepatitis C.Good Samaritan Hospital, Suffern NY, Medical Grand Rounds
- The Burden of Illness in Patients with IBS.Novartis Pharmaceuticals
- Join now to see all
Press Mentions
- 5 Must-Read Articles for GI Physicians This Week: Jan. 24-31January 31st, 2019
Professional Memberships
- Fellow
- Fellow
- Member
- American Association for the Study of Liver DiseaseFellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: